We next identified genes that distinguish the subpopulation of predicted-reactive KIR+CD8+ T cells in the blood and clonally related T cells in the tumor from all other CD8+ T cells in the blood and tumor, respectively. This evidence concerns the gene CD8A and neoplasm.